XORTX Therapeutics, Inc. (XRTX)
1.72
+0.02
(+1.18%)
USD |
NASDAQ |
Sep 24, 16:00
1.72
0.00 (0.00%)
After-Hours: 19:59
XORTX Therapeutics Total Return Level : 1.70 for Sept. 23, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 23, 2026 | 1.70 |
| September 22, 2026 | 1.86 |
| September 21, 2026 | 1.95 |
| September 18, 2026 | 1.92 |
| September 17, 2026 | 1.66 |
| September 16, 2026 | 1.78 |
| September 15, 2026 | 1.88 |
| September 14, 2026 | 2.07 |
| September 11, 2026 | 2.33 |
| September 10, 2026 | 2.11 |
| September 09, 2026 | 2.158 |
| September 08, 2026 | 2.28 |
| September 04, 2026 | 2.31 |
| September 03, 2026 | 2.15 |
| September 02, 2026 | 2.48 |
| September 01, 2026 | 2.16 |
| August 31, 2026 | 2.32 |
| August 28, 2026 | 2.338 |
| August 27, 2026 | 2.44 |
| August 26, 2026 | 2.218 |
| August 25, 2026 | 2.26 |
| August 24, 2026 | 2.00 |
| August 21, 2026 | 2.04 |
| August 20, 2026 | 2.02 |
| August 19, 2026 | 2.00 |
| Date | Value |
|---|---|
| August 18, 2026 | 2.047 |
| August 17, 2026 | 2.06 |
| August 14, 2026 | 2.155 |
| August 13, 2026 | 2.19 |
| August 12, 2026 | 2.161 |
| August 11, 2026 | 2.187 |
| August 10, 2026 | 2.16 |
| August 07, 2026 | 2.13 |
| August 06, 2026 | 2.03 |
| August 05, 2026 | 2.19 |
| August 04, 2026 | 2.16 |
| August 03, 2026 | 2.13 |
| July 31, 2026 | 2.12 |
| July 30, 2026 | 2.02 |
| July 29, 2026 | 2.06 |
| July 28, 2026 | 2.05 |
| July 27, 2026 | 2.02 |
| July 24, 2026 | 2.025 |
| July 23, 2026 | 2.10 |
| July 22, 2026 | 2.01 |
| July 21, 2026 | 2.04 |
| July 20, 2026 | 2.01 |
| July 17, 2026 | 2.01 |
| July 16, 2026 | 2.11 |
| July 15, 2026 | 2.01 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Lexaria Bioscience Corp. | 3.235 |
| InMed Pharmaceuticals, Inc. | 1.38 |
| Target Group, Inc. (Canada) | 0.0008 |
| NervGen Pharma Corp. | 1.96 |
| Milestone Pharmaceuticals, Inc. | 0.862 |